Hence then, the article about deepqure receives ide approval from fda for its efs study to treat resistant hypertension with its extravascular renal denervation technology hyperqure was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) )
Last updated :
Also on site :
- Decorated local aviator details his pursuit of recognition for his fellow shadow warriors of the Cold War
- Epstein weaponized in US midterm battles
- Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments .. DelveInsight